| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454145 | Lung Cancer | 2018 | 6 Pages |
Abstract
Analyses suggest that despite higher incidence of any grade drug-related fatigue compared with placebo in patients with advanced NSCLC, pemetrexed maintenance does not impair patient-reported QoL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Li Zhang, Chandra P. Belani, Ping-hai Zhang, Xin Wang, Lulu Yang, Mauro Orlando, Yi-long Wu,